Preying on Public Fears and Anxieties in a Pandemic: Businesses Selling Unproven and Unlicensed "Stem Cell Treatments" for COVID-19.
Identifieur interne : 000207 ( Main/Corpus ); précédent : 000206; suivant : 000208Preying on Public Fears and Anxieties in a Pandemic: Businesses Selling Unproven and Unlicensed "Stem Cell Treatments" for COVID-19.
Auteurs : Leigh TurnerSource :
- Cell stem cell [ 1875-9777 ] ; 2020.
English descriptors
- KwdEn :
- Betacoronavirus (MeSH), COVID-19 (MeSH), Commerce (MeSH), Coronavirus Infections (prevention & control), Coronavirus Infections (psychology), Coronavirus Infections (therapy), Fear (MeSH), Humans (MeSH), Marketing (MeSH), Pandemics (prevention & control), Pneumonia, Viral (prevention & control), Pneumonia, Viral (psychology), Pneumonia, Viral (therapy), SARS-CoV-2 (MeSH), Stem Cell Transplantation (economics), Stem Cell Transplantation (methods).
- MESH :
- economics : Stem Cell Transplantation.
- methods : Stem Cell Transplantation.
- prevention & control : Coronavirus Infections, Pandemics, Pneumonia, Viral.
- psychology : Coronavirus Infections, Pneumonia, Viral.
- therapy : Coronavirus Infections, Pneumonia, Viral.
- Betacoronavirus, COVID-19, Commerce, Fear, Humans, Marketing, SARS-CoV-2.
Abstract
In the midst of a global public health emergency, some businesses are taking advantage of widespread fears by marketing purported stem cell treatments for COVID-19. Such businesses target prospective clients with misleading claims, expose patients to potentially risky stem cell-based products, and undermine efforts to develop evidence-based treatments for COVID-19.
DOI: 10.1016/j.stem.2020.05.003
PubMed: 32464095
PubMed Central: PMC7203029
Links to Exploration step
pubmed:32464095Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Preying on Public Fears and Anxieties in a Pandemic: Businesses Selling Unproven and Unlicensed "Stem Cell Treatments" for COVID-19.</title>
<author><name sortKey="Turner, Leigh" sort="Turner, Leigh" uniqKey="Turner L" first="Leigh" last="Turner">Leigh Turner</name>
<affiliation><nlm:affiliation>Center for Bioethics, School of Public Health, and College of Pharmacy, University of Minnesota, 410 Church Street SE, N520, Minneapolis, MN 55455, USA. Electronic address: turne462@umn.edu.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32464095</idno>
<idno type="pmid">32464095</idno>
<idno type="doi">10.1016/j.stem.2020.05.003</idno>
<idno type="pmc">PMC7203029</idno>
<idno type="wicri:Area/Main/Corpus">000207</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000207</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Preying on Public Fears and Anxieties in a Pandemic: Businesses Selling Unproven and Unlicensed "Stem Cell Treatments" for COVID-19.</title>
<author><name sortKey="Turner, Leigh" sort="Turner, Leigh" uniqKey="Turner L" first="Leigh" last="Turner">Leigh Turner</name>
<affiliation><nlm:affiliation>Center for Bioethics, School of Public Health, and College of Pharmacy, University of Minnesota, 410 Church Street SE, N520, Minneapolis, MN 55455, USA. Electronic address: turne462@umn.edu.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Cell stem cell</title>
<idno type="eISSN">1875-9777</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Betacoronavirus (MeSH)</term>
<term>COVID-19 (MeSH)</term>
<term>Commerce (MeSH)</term>
<term>Coronavirus Infections (prevention & control)</term>
<term>Coronavirus Infections (psychology)</term>
<term>Coronavirus Infections (therapy)</term>
<term>Fear (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Marketing (MeSH)</term>
<term>Pandemics (prevention & control)</term>
<term>Pneumonia, Viral (prevention & control)</term>
<term>Pneumonia, Viral (psychology)</term>
<term>Pneumonia, Viral (therapy)</term>
<term>SARS-CoV-2 (MeSH)</term>
<term>Stem Cell Transplantation (economics)</term>
<term>Stem Cell Transplantation (methods)</term>
</keywords>
<keywords scheme="MESH" qualifier="economics" xml:lang="en"><term>Stem Cell Transplantation</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Stem Cell Transplantation</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pandemics</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term>
<term>COVID-19</term>
<term>Commerce</term>
<term>Fear</term>
<term>Humans</term>
<term>Marketing</term>
<term>SARS-CoV-2</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">In the midst of a global public health emergency, some businesses are taking advantage of widespread fears by marketing purported stem cell treatments for COVID-19. Such businesses target prospective clients with misleading claims, expose patients to potentially risky stem cell-based products, and undermine efforts to develop evidence-based treatments for COVID-19.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32464095</PMID>
<DateCompleted><Year>2020</Year>
<Month>06</Month>
<Day>12</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>12</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1875-9777</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>26</Volume>
<Issue>6</Issue>
<PubDate><Year>2020</Year>
<Month>06</Month>
<Day>04</Day>
</PubDate>
</JournalIssue>
<Title>Cell stem cell</Title>
<ISOAbbreviation>Cell Stem Cell</ISOAbbreviation>
</Journal>
<ArticleTitle>Preying on Public Fears and Anxieties in a Pandemic: Businesses Selling Unproven and Unlicensed "Stem Cell Treatments" for COVID-19.</ArticleTitle>
<Pagination><MedlinePgn>806-810</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S1934-5909(20)30201-0</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.stem.2020.05.003</ELocationID>
<Abstract><AbstractText>In the midst of a global public health emergency, some businesses are taking advantage of widespread fears by marketing purported stem cell treatments for COVID-19. Such businesses target prospective clients with misleading claims, expose patients to potentially risky stem cell-based products, and undermine efforts to develop evidence-based treatments for COVID-19.</AbstractText>
<CopyrightInformation>Copyright © 2020 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Turner</LastName>
<ForeName>Leigh</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Center for Bioethics, School of Public Health, and College of Pharmacy, University of Minnesota, 410 Church Street SE, N520, Minneapolis, MN 55455, USA. Electronic address: turne462@umn.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>05</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Cell Stem Cell</MedlineTA>
<NlmUniqueID>101311472</NlmUniqueID>
<ISSNLinking>1875-9777</ISSNLinking>
</MedlineJournalInfo>
<SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003132" MajorTopicYN="N">Commerce</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
<QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005239" MajorTopicYN="N">Fear</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D040541" MajorTopicYN="Y">Marketing</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
<QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D033581" MajorTopicYN="N">Stem Cell Transplantation</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
</MeshHeadingList>
<CoiStatement>Declaration of Interests L.T. has reported to the FDA numerous businesses selling unlicensed and unproven stem cell interventions. On a pro bono basis, L.T. filed an expert opinion report and rebuttal report supporting plaintiffs in a lawsuit filed against a business marketing purported stem cell interventions. L.T. was also deposed in this case and was examined and cross-examined in a court hearing. This work was also conducted on a pro bono basis. L.T. is a member of the International Society for Cell and Gene Therapy and a member of the International Society for Stem Cell Research.</CoiStatement>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>5</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>6</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>5</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32464095</ArticleId>
<ArticleId IdType="pii">S1934-5909(20)30201-0</ArticleId>
<ArticleId IdType="doi">10.1016/j.stem.2020.05.003</ArticleId>
<ArticleId IdType="pmc">PMC7203029</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>JAMA. 2020 Mar 24;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32208486</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Sci Transl Med. 2017 Jul 5;9(397):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28679655</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Medicine (Baltimore). 2020 Jul 31;99(31):e21429</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32756149</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2016 May 13;352(6287):776-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27174977</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Stem Cell. 2016 Aug 4;19(2):154-157</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27374789</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur Respir J. 2020 Jun 4;55(6):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32265310</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pain Physician. 2020 Mar;23(2):E71-E83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32214286</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>NPJ Regen Med. 2018 Feb 19;3:5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29479481</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Aging Dis. 2020 Mar 9;11(2):216-228</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32257537</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Wicri/explor/CovidPublicV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000207 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000207 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Wicri |area= CovidPublicV1 |flux= Main |étape= Corpus |type= RBID |clé= pubmed:32464095 |texte= Preying on Public Fears and Anxieties in a Pandemic: Businesses Selling Unproven and Unlicensed "Stem Cell Treatments" for COVID-19. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:32464095" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a CovidPublicV1
This area was generated with Dilib version V0.6.38. |